• Latest Posts

Biogen acquiring Reata Pharmaceuticals for $7.3B

AbbVie takes step forward in Europe with migraine drug


New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results

PharmEnable raises $7.5M to develop small molecule drugs to treat cancer and neurological diseases

New epilepsy study could lead to new treatment options

Sania Therapeutics launches to advance neural circuit dysfunction medicines

Five latest advancements in Tourette’s syndrome research